Loading candles…
Vaishali Pharma Ltd, incorporated in 1989, operates in the pharmaceutical industry focusing on the marketing and distribution of pharmaceutical products. The company's product portfolio includes active pharmaceutical ingredients (APIs) and finished dosage formulations. Serving as an intermediary in the supply chain, Vaishali Pharma Ltd facilitates the availability of these products in domestic and international markets. Its business segments encompass marketing and distribution activities. The company emphasizes emerging economies, particularly in Africa and Southeast Asia, alongside its presence in India. There is no publicly available information on founders, key management, subsidiaries, or stock exchange listings.
This page is a live market overview for VAISHALI PHARMA LIMITED (VAISHALI) on the NSE. As a listed security, VAISHALI PHARMA LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for VAISHALI before placing trades on tick2trade.
As of the latest feed, VAISHALI last traded at ₹7.88 on NSE, down ₹0.1 (1.25%) from the previous close of ₹7.98. Today's session range is ₹7.82 – ₹8.19, against a 52-week band of ₹4.75 – ₹13.05. Traded volume today stands at 88.80K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for VAISHALI in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether VAISHALI is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for VAISHALI PHARMA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in VAISHALI. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated VAISHALI option chain page linked from this overview.
| Fund Raising | To consider Fund Raising | 8 Jul 2026 |
| Fund Raising | To consider Fund Raising and other business matters | 2 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and other business matters | 30 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 13 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 14 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | 11 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and other business matters | 28 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.